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Introduction 
The quantity and quality of drug delivered to the 
distal airways by nebulization is operator dependent 
(1). We have previously reported a variety of tech- 
niques practised for administering drugs via nebulizer 
(2) and deficiencies in the method of nebulizer opera- 
tion have been highlighted (3). In the following study 
we examined the impact of issuing guidelines for 
nebulization (see Appendix), on the many variables 
involved. In addition we investigated whether 
reinforcement of the guidelines by pharmacist-led 
tutorials improved compliance with the guidelines. 
Methods 
Thirty-five wards within Glasgow Royal Infirmary 
were sampled using an open questionnaire. Prior to 
the study information was collected on: drugs nebu- 
lized, diluent and final fill volume, driving gas and 
flow-rate, sequence of drug administration, and 
nebulizer care and cleanliness. 
Group 1 wards received guidelines plus 
pharmacist-led tutorials. Group 2 wards received 
guidelines alone. A second survey was carried out 6-8 
weeks later. 
For both surveys the nurse-in-charge was 
interviewed. 
Statistical analysis was performed using non- 
parametric chi-squared or’) analysis. 
Results 
Group 1 comprised 14 wards, (A) prior to guide- 
line circulation, (B) after guidelines were reinforced 
by ward pharmacists. Group 2 comprised 21 wards, 
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(A) prior to guideline circulation, and (B) after the 
guidelines. 
DRUGS NEBULIZED 
Drugs nebulized were similar between groups with 
salbutamol used in all wards, ipratropium bromide 
and normal saline less commonly used. Terbutaline 
and pentamidine isethionate were rarely used. 
DILUENT AND FINAL VOLW 
All respondents diluted nebulizer solution before 
administration. The diluent favoured was normal 
saline (12,13,16,20 in groups 1 A, lB, 2A, 2B, respec- 
tively). More respondents used a final fill volume of 
4 ml or greater after guideline circulation (2,11,5,14 
in groups lA, lB, 2A, 2B, respectively). 
DRIVING GAS AND FLOW-RATE 
Choice of driving gas did not differ significantly 
(Table 1). Before guidelines most respondents (69%) 
used a flow-rate less than 6 1 min- i (Table 1). After 
guidelines alone the use of a flow-rate greater than 
6 1 min- ’ did not change significantly. However, 
those receiving tutorial reinforcement showed signifi- 
cant improvement k’ 3.89, PcO.05) with the percent- 
age using a flow-rate greater than 6 1 min- ’ rising 
from 7% to 50%. 
SEQUENCE OF DRUG ADMINISTRATION 
Following guideline circulation those willing to 
administer both salbutamol and ipratropium bro- 
mide in the same nebulizer increased significantly 
in both groups [6 (lA)-11 (lB), x2 8.03, PcO.05; 
4 (2A)-14 (2B), x2 7.26, P<O.Ol]. 
RE-USE AND CARE OF THE NEBULIZER 
All wards except casualty re-used nebulizers for the 
same individuals. Cleansing procedures varied 
greatly. No significant difference in practice followed 
circulation of guidelines with or without tutorials. 
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Table I Driving gas selected and flow rate expressed as frequency (‘l/o wards in group) 
Group IA 
Pre-guidelines 
Group IB 
After guidelines 
and tutorials 
Group 2A 
Pre-guidelines 
Group 2B 
After guidelines 
alone 
Driving gas: 
Oxygen 
Air 
Air unless prescribed oxygen 
Oxygen unless air prescribed 
Both 
As prescribed 
Oxygen asthmatics, air COAD 
Flow-rate: 
~61 min ’ 
261 mini’ 
unspecified 
1 (7) 3 (21) 6 (29) 5 (25) 
8 (57) 6 (43) g (38) 6 (29) 
2 (14) 1 (5) 3 (14) 
1 (7) 1 (5) 
1 (7) 3 (21) 5 (24) 3 (14) 
- 1 (5) 
1 (7) 2 (14) 3 (14) 
9 (64) 7 (50) 15 (71) 19 (90) 
1 (7) 7 (50)* 5 (24) 2 (10) 
4 (29) 1 (5) 
*P<O,O5. COAD, Chronic Obstructive Airways Disease. 
Discussion 
The data presented highlight the wide range of 
techniques used in administering drugs by nebulizer. 
Guidelines on optimal procedure only occasionally 
improved technique and the contribution of tutorial 
reinforcement was disappointingly limited. 
Many aspects of this study require further 
comment. Where a patient was prescribed both 
salbutamol and ipratropium bromide those willing to 
mix the two solutions increased significantly after the 
guidelines were circulated. Such practice is appropri- 
ate since unnecessarily prolonged nebulization may 
decrease patient compliance. The mixing of nebulized 
drugs is widespread (4) and in limited experimental 
studies, there has been no evidence of hazardous 
interactions (5,6). 
The diluent favoured by the majority was normal 
saline. However following the circulation of guide- 
lines, two respondents still favoured water. Since 
water produces a hypotonic solution which may 
induce bronchospasm (7) this practice is potentially 
hazardous. 
Our guidelines recommended an optimal fill vol- 
ume of 4 ml, balancing residual volume with time to 
nebulize. Before the guidelines were circulated most 
respondents used a volume less than 4 ml (71%). 
After guidelines 71% used a fill volume of 4 ml or 
greater. This change was not significant but may go 
some way toward standardizing the fractional dose of 
drug delivered. 
The driving gas used varied greatly and was not 
influenced by guidelines. This remains an area of 
concern. Although it is safe to drive nebulizers with 
with a normal blood gas picture, caution should be 
exercised in those with type 2 respiratory failure with 
carbon dioxide retention (8). Air as a driving gas in 
severe asthmatics with type 1 respiratory failure is 
inappropriate given their hypoxia. The failure of 
both guidelines and tutorials to improve practice is 
disappointing. 
A flow-rate of 6 1 min ~ ’ is required to ensure 
satisfactory particle size distribution for distal air- 
ways deposition (9). Flow-rate was not significantly 
altered following guideline circulation alone. How- 
ever, the tutorials significantly increased the number 
who used an appropriate flow-rate. 
Nebulizer cleansing was not significantly altered by 
guideline circulation. In retrospect the practicality of 
our guidelines is questionable as only one respondent 
described the recommended practice after guideline 
circulation. A practical and acceptable procedure 
for nebulizer care and cleanliness therefore still needs 
to be defined, to minimize the risk of bacterial 
colonization of equipment (10-12). 
It is disappointing that the implementation of 
nebulization guidelines with or without reinforce- 
ment by pharmacist tutorial was not more successful 
in improving technique. 
Given the increasingly widespread use of 
nebulizers, the education of those involved in pre- 
scribing, supplying and supervising nebulized therapy 
is essential. This study highlights the difficulties of 
ensuring that good practice follows guidelines. 
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Appendix 
GUIDELINES FOR THE NEBULIZATION OF RESPIRATORY SOLUTIONS 
1. Sit the patient up, either in bed or in a chair. Make him/her comfortable. Advise the patient to 
breathe gently through the mouth and encourage relaxation. The face mask should fit comfortably. 
2. Check the expiry date on the respirator solution. If a multidose bottle is being used it must be 
discarded one month after opening. Record date opened on container. 
3. Use sterile normal saline as diluent. Water will result in hypotonic solutions which may cause 
broncho-constriction. The most economic form of sodium chloride 0.9% for this purpose is Normasol 
sachets. The sachet may be used for more than one patient during the drug administration round but must 
be discarded immediately thereafter. 
4. Draw up all solutions with sterile needle and syringe. For a drug administration round there is no 
need to change the needle and syringe when drawing up the same drug for use in a number of patients. 
5. A final volume of 4 ml is recommended. The diluent may be poured in up to the 4-ml mark. Given 
that all nebulizers have a residual volume, this quantity allows an average 80% of the drugs to be delivered 
in a time acceptable to the patient. (approx, 10 min). 
6. Use a flow rate of 6 litres per minute. This will deliver at least 65% of the droplets of a size below 
5 u. This size is required for adequate drug penetration into distal airways. 
7. Use oxygen as the driving gas in patients who are young and who have asthma. Use air as the 
driving gas in patients who have chronic bronchitis and evidence of carbon dioxide retention. 
(PCO,>40 mmHg.[53 kPa]). If patients with CO, retention are receiving controlled oxygen this 
should be discontinued for the duration of the nebulization only and restarted immediately at the end of the 
10 minute nebulization. 
8. Tap the nebulizer during nebulization. This shakes down large droplets and ensures maximum 
delivery of the drug. 
9. Rinse the nebulizer with sterile water, wipe dry with a paper towel and dry the inner tube 
using compressed air or oxygen. Cleansing is important to reduce the risk of bacterial contamination 
and prevent build up of crystallized drug in the nebulizer. Store the nebulizer in a bag with the patients’ 
name on it. 
10. In patients receiving a combination of salbutamol and ipratopium the drugs may be mixed immediately 
before use and administered as one nebulization. Do not mix other combinations before checking 
with pharmacy. 
